Consumers Association of Penang

Giving voice to the little people...since 1970

Clear the confusion over motor policy

The Ministry of Finance and Bank Negara Malaysia owes the public an explanation over conflicting reports about the proposed Third Party Bodily Injury and Death Benefits (TPBID) which is going to replace the third-party motor insurance.

On one hand Bank Negara (which comes under the Ministry of Finance) has said that the TPBID policy is not finalized and has invited the public to give its feedback on it. CAP too submitted its comments on 14th May 2010.

24% interest rate for co-op loan

Cooperative members may find it easy to get loans but these loans can be very expensive.  For one cooperative member, the interest rate is as high as 24% per annum.  

The loan is expensive because the cooperative deducts “cost of loan 19% from the principal”.

CAP and SAM: Revoke approval for field trial of GM mosquitoes

 
gm-mozzie-idrisCAP and Sahabat Alam Malaysia (SAM) call upon the National Biosafety Board (NBB) to revoke the approval given to the Institute for Medical Research (IMR) in October 2010 to release genetically modified (GM) male Aedes aegypti mosquitoes for the purpose of a field experiment.
 
The applicant and implementer of the field trial is the IMR which had developed the GM mosquitoes in a joint research with UK-based biotech company Oxitec Ltd. The field trial which was supposed to be carried out last December in uninhabited and inhabited sites in the districts of Bentong, Pahang and Alor Gajah, Melaka was reportedly delayed because of bad weather.

Consumers deserve a No-Fault Liability Motor Scheme

The Consumers Association of Penang (CAP) welcomes the announcement by Bank Negara Malaysia (BNM) that it will be consulting all relevant stakeholders next month before presenting the proposed new third party bodily injury and death scheme to the government.

In August 2007, the Attorney General’s Chambers issued a Preliminary Issue paper proposing that a No-Fault Liability Scheme (NFL) be introduced.  There were intensive discussions with all interested parties including BNM on the need for the NFL scheme.
 

Risk Assessment of GM mosquito planned release is incomplete and lacks transparency, says GeneWatch UK

 The Risk Assessment (RA) report of the Malaysian Genetic Modification Advisory Committee (GMAC) on the planned release of GM Aedes mosquitoes in Malaysia is incomplete and the RA process needs to be more transparent. These comments were made in a 13-page report by GeneWatch UK, a scientific organisation involved in genetic engineering and biosafety issues.

GeneWatch UK states that ‘We are concerned that the novelty of this application of GM technology has made regulators in several countries too dependent on advice provided by the company, which has a vested interest in speeding its products into the market place in order to generate financial returns for its investors’.
 
Malaysia’s field release of GM Aedes mosquitoes, purportedly developed by the IMR and the UK based biotech company Oxitec, will be one of the first such experiments in the world.